Publications by authors named "Gerhild Wildner"

Claim this Profile
C
Case Report: Treating one autoimmune disease induces another: the paradox of TNF-alpha inhibitor therapies.
Miranda Gehrke, Stephan Thurau, Gerhild Wildner

Front Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel platform for engineered AAV-based vaccines.
Sabrina Babutzka, Miranda Gehrke, Anastasia Papadopoulou, Maria Diedrichs-Möhring, Maria Giannaki, Gerhild Wildner

Mol Ther Methods Clin Dev· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenic Switch of RPE Cells.
Andjela Sekulic, Gerhild Wildner, Christine Skerka, Olaf Strauß

Adv Exp Med Biol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posterior subcapsular cataracts are a late effect after acute exposure to 0.5 Gy ionizing radiation in mice.
Sarah Kunze, Alexander Cecil, Cornelia Prehn, Gabriele Möller, Andreas Ohlmann, Gerhild Wildner

Int J Radiat Biol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenesis of Bacterial Uveitis.
Gerhild Wildner, Reema Bansal, Nikitha Ayyadurai, Stephan Thurau, Soumyava Basu

Ocul Immunol Inflamm· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased plasma level of terminal complement complex in AMD patients: potential functional consequences for RPE cells.
Catharina Busch, Saskia Rau, Andjela Sekulic, Luce Perie, Christian Huber, Gerhild Wildner

Front Immunol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antigenic mimicry - The key to autoimmunity in immune privileged organs.
Gerhild Wildner

J Autoimmun· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Ocular side effects of modern oncological therapy : Immunological checkpoint and MEK/BRAF signal transduction inhibitors].
Stephan Thurau, Gerhild Wildner, Maria-Andreea Gamulescu

Ophthalmologie· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uveitis in Tumor Patients Treated with Immunological Checkpoint- and Signal Transduction Pathway-Inhibitors.
Stephan Thurau, Hendrik Engelke, Peter McCluskey, Richard J Symes, Eline Whist, Gerhild Wildner

Ocul Immunol Inflamm· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FoxP3 expression by retinal pigment epithelial cells: transcription factor with potential relevance for the pathology of age-related macular degeneration.
Ahmad Samir Alfaar, Lucas Stürzbecher, Maria Diedrichs-Möhring, Marion Lam, Christophe Roubeix, Gerhild Wildner

J Neuroinflammation· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new small molecule DHODH-inhibitor [KIO-100 (PP-001)] targeting activated T cells for intraocular treatment of uveitis - A phase I clinical trial.
Stephan Thurau, Christoph M E Deuter, Arnd Heiligenhaus, Uwe Pleyer, Joachim Van Calster, Gerhild Wildner

Front Med (Lausanne)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of Novel AAV Capsids for Retinal Gene Therapy.
Miranda Gehrke, Maria Diedrichs-Möhring, Jacqueline Bogedein, Hildegard Büning, Stylianos Michalakis, Gerhild Wildner

Cells· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumors, tumor therapies, autoimmunity and the eye.
Gerhild Wildner

Autoimmun Rev· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Mimicry and Uveitis.
Gerhild Wildner, Maria Diedrichs-Möhring

Front Immunol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is glaucoma an autoimmune disease?
Denis Wakefield, Gerhild Wildner

Clin Transl Immunology· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of IFN-alpha in Experimental and Clinical Uveitis.
Xiaoli Liu, Maria Diedrichs-Möhring, Gerhild Wildner

Ocul Immunol Inflamm· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resolution of uveitis.
Gerhild Wildner, Maria Diedrichs-Möhring

Semin Immunopathol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are rats more human than mice?
Gerhild Wildner

Immunobiology· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The immunopathogenesis of chronic and relapsing autoimmune uveitis - Lessons from experimental rat models.
Maria Diedrichs-Möhring, Ulrike Kaufmann, Gerhild Wildner

Prog Retin Eye Res· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraocular DHODH-inhibitor PP-001 suppresses relapsing experimental uveitis and cytokine production of human lymphocytes, but not of RPE cells.
Maria Diedrichs-Möhring, Sandy Niesik, Claudia S Priglinger, Stephan R Thurau, Franz Obermayr, Gerhild Wildner

J Neuroinflammation· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anaphylatoxins Activate Ca, Akt/PI3-Kinase, and FOXO1/FoxP3 in the Retinal Pigment Epithelium.
Catharina Busch, Balasubramaniam Annamalai, Khava Abdusalamova, Nadine Reichhart, Christian Huber, Gerhild Wildner

Front Immunol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Dry eye disease and uveitis: A closer look at immune mechanisms in animal models of two ocular autoimmune diseases" [AUTREV 15-12 (2016) 1181-1192].
Tanima Bose, Maria Diedrichs-Möhring, Gerhild Wildner

Autoimmun Rev· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycosaminoglycans are important mediators of neutrophilic inflammation in vivo.
Martha Gschwandtner, Elisabeth Strutzmann, Mauro M Teixeira, Hans J Anders, Maria Diedrichs-Möhring, Gerhild Wildner

Cytokine· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory eye disease: Pre-treatment assessment of patients prior to commencing immunosuppressive and biologic therapy: Recommendations from an expert committee.
Denis Wakefield, Peter McCluskey, Gerhild Wildner, Stephan Thurau, Gregory Carr

Autoimmun Rev· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dry eye disease and uveitis: A closer look at immune mechanisms in animal models of two ocular autoimmune diseases.
Tanima Bose, Maria Diedrichs-Möhring, Gerhild Wildner

Autoimmun Rev· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis